Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease
Patrick Lipps, Ana Beatriz Ayroza Galvão Ribeiro Gomes, Laila Kulsvehagen, Matthias A. Mutke, Jens Kühle, Athina Papadopoulou, Anne‐Katrin Pröbstel
Abstract
This cross-sectional study examines whether proposed myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD) diagnostic criteria can exclude other diseases, such as multiple sclerosis, and rely on results of cell-based assays.
Topics & Concepts
Myelin oligodendrocyte glycoproteinMultiple sclerosisOligodendrocyteMyelinDiseaseAntibodyImmunologyMedicineGlycoproteinDemyelinating diseaseMyelin-associated glycoproteinPathologyBiologyCentral nervous systemInternal medicineGeneticsExperimental autoimmune encephalomyelitisMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersNeurogenesis and neuroplasticity mechanisms